Keith L Agre M D Medical Corporation is categorized under Internal Medicine Doctors in Los Angeles, CA and active since 2013.
Keith L Agre M D Medical Corporation was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 1125 South Beverly Drive # 110, Los Angeles, California CA 90035 or by phoning (310) 276-2033. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Keith L Agre M D Medical Corporation |
Address: | 1125 South Beverly Drive # 110, Los Angeles, California 90035 |
Phone Number: | (310) 276-2033 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Keith L Agre M D Medical Corporation was started in 2013 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Keith L Agre M D Medical Corporation by calling the company number (310) 276-2033, as your correspondence is most welcome. Additionally, the physical location of the single location of Keith L Agre M D Medical Corporation can be found at the coordinates 34.056743,-118.396636 as well as the street address 1125 South Beverly Drive # 110 in Los Angeles, California 90035.
For its online presence, you may visit Keith L Agre M D Medical Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.